StockData
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc. (SGMT) stock

SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$10.11+0.26 (+2.64%)

Close on Nov 18, 2026Market cap $628.42MP/E –Yield –

Sagimet Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Sagimet Biosciences's revenue for the twelve months ending Dec 31, 2023 was $2.00M. For fiscal 2023 it was $2.00M.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$2.00M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$2.00M–

More Sagimet Biosciences figures

See a number that looks wrong?